Turner’s Syndrome – genetic, diagnostic methods and clinical treatment
DOI:
https://doi.org/10.12775/JEHS.2023.15.01.020Keywords
Turner’s syndrome, sex chromosome aneuploidies, growth hormone, onadal dysgenesisAbstract
Introduction : Turner syndrome (TS) is one of the most common genetic disorders affecting approximatley 1 in 2,000-25000 live-born girls. TS is the result of complete oraz partial monosomy of the C chromosome. About half have monosomy X (45,X) and 5-10% have duplication (isochromosome) of the long arm of one X (46,X,i(Xq)). Most of the rest have mosaicism.(1)
The aim of the study: The purpose of this review paper is to present the observations regarding this disease, including epidemiology, diagnosis and detailed examination of the individual needs of the patient affected by the disease.
Matrials and methods: This review was based on available data collected in the PubMed database and Google Scholar web serach engine, using key words: Turner’s syndrome, diagnosis of Turner Syndrome, sex chromosome aneuploidies
Summary: The article draws attention to the complexity of Turner syndrome, the variety of symptoms and the progress in the diagnosis and therapy of this disease. Early diagnosis, specialist care and modern therapeutic methods have a positive impact on the quality of life of TS patients. Future studies of molecular mechanisms and therapeutic efficacy may improve the care of patients affected by this rare disease.
References
Ranke MB, Saenger P. Turner's syndrome. Lancet. 2001 Jul 28;358(9278):309-14. doi: 10.1016/S0140-6736(01)05487-3. PMID: 11498234.
Grzegorz H. Bręborowicz: Położnictwo i Ginekologia, wyd.3, 2020
Kesler SR. Turner syndrome. Child Adolesc Psychiatr Clin N Am. 2007 Jul;16(3):709-22. doi: 10.1016/j.chc.2007.02.004. PMID: 17562588; PMCID: PMC2023872.
Sybert VP, McCauley E. Turner's syndrome. N Engl J Med. 2004 Sep 16;351(12):1227-38. doi: 10.1056/NEJMra030360. PMID: 15371580.
Hjerrild BE, Mortensen KH, Gravholt CH. Turner syndrome and clinical treatment. Br Med Bull. 2008;86:77-93. doi: 10.1093/bmb/ldn015. Epub 2008 Apr 9. PMID: 18400842.
Loscalzo ML. Turner syndrome. Pediatr Rev. 2008 Jul;29(7):219-27. doi: 10.1542/pir.29-7-219. PMID: 18593751.
Hjerrild BE, Mortensen KH, Gravholt CH. Turner syndrome and clinical treatment. Br Med Bull. 2008;86:77-93. doi: 10.1093/bmb/ldn015. Epub 2008 Apr 9. PMID: 18400842.
Gravholt CH, Viuff MH, Brun S, Stochholm K, Andersen NH. Turner syndrome: mechanisms and management. Nat Rev Endocrinol. 2019 Oct;15(10):601-614. doi: 10.1038/s41574-019-0224-4. Epub 2019 Jun 18. PMID: 31213699.
Cui X, Cui Y, Shi L, Luan J, Zhou X, Han J. A basic understanding of Turner syndrome: Incidence, complications, diagnosis, and treatment. Intractable Rare Dis Res. 2018 Nov;7(4):223-228. doi: 10.5582/irdr.2017.01056. PMID: 30560013; PMCID: PMC6290843.
Augoulea A, Zachou G, Lambrinoudaki I. Turner syndrome and osteoporosis. Maturitas. 2019 Dec;130:41-49. doi: 10.1016/j.maturitas.2019.09.010. Epub 2019 Sep 25. PMID: 31706435.
Ford CE, Jones KW, Polani PE, De Almeida JC, Briggs JH. A sex-chromosome anomaly in a case of gonadal dysgenesis (Turner's syndrome). Lancet. 1959; 1:711- 713.
Baena N, De Vigan C, Cariati E, Clementi M, Stoll C, Caballín MR, Guitart M. Turner syndrome: Evaluation of prenatal diagnosis in 19 European registries. Am J Med Genet A. 2004; 15:16-20.
Zhang F, Zhang Z. Advances in the study of the diagnosis and treatment of Turner syndrome. Journal of China-Japan Friendship Hospital. 2015; 29:192-194. (in Chinese)
WWolff DJ, Van Dyke DL, Powell CM, Working Group of the ACMG Laboratory Quality Assurance Committee. Laboratory guideline for Turner syndrome. Genet Med. 2010; 12:52-55.
Berg JS, Powell CM. Potential Uses and Inherent Challenges of Using Genome-Scale Sequencing to Augment Current Newborn Screening. Cold Spring Harb Perspect Med. 2015 Oct 5;5(12):a023150. doi: 10.1101/cshperspect.a023150. PMID: 26438605; PMCID: PMC4665041.
Bodian DL, Klein E, Iyer RK, Wong WS, Kothiyal P, Stauffer D, Huddleston KC, Gaither AD, Remsburg I, Khromykh A, Baker RL, Maxwell GL, Vockley JG, Niederhuber JE, Solomon BD. Utility of whole-genome sequencing for detection of newborn screening disorders in a population cohort of 1,696 neonates. Genet Med. 2016 Mar;18(3):221-30. doi: 10.1038/gim.2015.111. Epub 2015 Sep 3. PMID: 26334177.
Ullrich, O., Über typische Kombinationsbilder multipler Abartungen. Zeitschrift für Kinderheilkunde, 1930, 49(3): p. 271-276.
Turner, H.H., A syndrome of infantilism, congenital webbed neck and cubitus valgus. Endocrinology, 1938. 23(5): p. 566-574.
Hook EB, Warburton D. The distribution of chromosomal genotypes asso- ciated with Turner’s syndrome: livebirth prevalence rates and evidence for diminished fetal mortality and severity in genotypes associated with struc- tural X abnormalities or mosaicism. Hum Genet 1983;64:24–27.
Held KR, Kerber S, Kaminsky E, et al. Mosaicism in 45,X Turner syndrome: does survival in early pregnancy depend on the presence of two sex chro- mosomes? Hum Genet 1992;88:288–294.
Davenport ML, Crowe BJ, Travers SH, Rubin K, Ross JL, Fechner PY, Gunther DF, Liu C, Geffner ME, Thrailkill K, Huseman C, Zagar AJ, Quigley CA. Growth hormone treatment of early growth failure in toddlers with Turner syndrome: A randomized, controlled, multicenter trial. J Clin Endocrinol Metab. 2007; 92:3406-3416. [PubMed] [Google Scholar]
Linglart A, Cabrol S, Berlier P, Stuckens C, Wagner K, de Kerdanet M, Limoni C, Carel JC, Chaussain JL, French Collaborative Young Turner Study Group. Growth hormone treatment before the age of 4 years prevents short stature in young girls with Turner syndrome. Eur J Endocrinol. 2011; 164:891-897.
Bondy CA. Turner Syndrome Study Group. Care of girls and women with Turner syndrome: A guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab. 2007; 92:10-25.
Spencer, K., Tul, N., & Nicolaides, K. H. (2000). Maternal serum free ?-hCG and PAPP-A in fetal sex chromosome defects in the first trimester. Prenatal Diagnosis, 20(5), 390–394
Non-invasive prenatal test in the diagnosis of aneuploidy 13, 18 and 21 – theoretical and practical aspects Stembalska Agnieszka1, Łaczmańska Izabela1, Dudarewicz Lech2
Chorionic Villus Sampling in cytogenetic analysis – disadvantages and advantages Gnyś-Wiercioch Agnieszka, Bloch Renata, Grolik Barbara, Hadaś Jolanta, Kania Agnieszka, Szołtysik-Szot Mariola, Sodowska Henryka
Zhang Q, Guo X, Tian T, Wang T, Li Q, Wang L, Liu Y, Xing Q, He L, Zhao X. Detection of Turner syndrome using X-chromosome inactivation specific differentially methylated CpG sites: A pilot study. Clinica Chimica Acta. 2017; 468:174-179.
Non-invasive prenatal testing: a review of international implementation and challenges Megan Allyse, Mollie A Minear, Elisa Berson,Shilpa Sridhar,Margaret Rote,Anthony Hung & Subhashini Chandrasekharan
Rekomendacje Polskiego Towarzystwa Ginekologów i Położników oraz Polskiego Towarzystwa Genetyki Człowieka dotyczące badań przesiewowych oraz diagnostycznych badań genetycznych wykonywanych w okresie prenatalnym Opublikowano: 11/04/2022
Zespół Turnera – postępowanie diagnostyczno-terapeutyczne prof. dr hab. n. med. Aneta Gawlik Katedra i Klinika Pediatrii i Endokrynologii Dziecięcej z Pododdziałem Zaburzeń Rozwoju Płci, Śląski Uniwersytet Medyczny w Katowicach
Gravholt CH, Andersen NH, Conway GS, et al.; International Turner Syndrome Consensus Group. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol 2017;177(3):G1-70
Bettendorf M, Inta IM, Doerr HG, Hauffa BP, Mehls O, Ranke MB. Height gain in Ullrich-Turner syndrome after early and late growth hormone treatment start: results from a large retrospective German study and potential basis for an individualized treatment approach. Horm Res Paediatr. 2013;80(5):356-62. doi: 10.1159/000356045. Epub 2013 Nov 6. PMID: 24217296.
Blum WF, Ross JL, Zimmermann AG, Quigley CA, Child CJ, Kalifa G, Deal C, Drop SL, Rappold G, Cutler GB Jr. GH treatment to final height produces similar height gains in patients with SHOX deficiency and Turner syndrome: Results of a multicenter trial. J Clin Endocrinol Metab. 2013; 98:1383-1392.
Ari M, et al. The effects of growth hormone treatment on bone mineral density and bodycomposition in girls with Turner syndrome. J Clin Endocrinol Metab 2006;91(11):4302–5.
Gravholt CH. Clinical practice in Turner syndrome. Nat Clin Pract Endocrinol Metab 2005;1(1):41–52.
Bannink E.M., Raat H., Mulder P.G. et al.; Quality of life after growth hormone therapy and induced puberty in women with Turner syndrome; J. Pediatr. 2006:148, 95-101
Kanaka-Gantenbein C.; Hormone replacement treatment in Turner syndrome; Pediatr. Endocrinol. Rev. 2006:3 Suppl 1, 214-218
Ma Y, Xu Z. Advances in the diagnosis and treatment of Turner syndrome. Chin J Postgrad Med. 2013; 36:72-75. (in Chinese)
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Aleksandra Łokczewska-Bojar, Rami Ben Rhaiem, Przemysław Kępka, Daria Kuziemkowska, Jan Kuźma, Anna Łącka-Majcher, Grzegorz Tarsa, Magdalena Skotalczyk, Zuzanna Sawińska, Katarzyna Sudelska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 277
Number of citations: 0
